Psoriatic Arthritis Treatment Market Size, Industry Trends | Analysis 2024-2032

(MENAFN- Meridian Market Consultants) The Reports and Insights, a leading market research company, has recently releases report titled “Psoriatic Arthritis (PsA) treatment Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2032.” The study provides a detailed analysis of the industry, including the global Psoriatic Arthritis (PsA) Treatment Market Share, size, trends, and growth forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.

Report Highlights:

How big is the Psoriatic Arthritis (PsA) Treatment Market?

The global Psoriatic Arthritis (PsA) treatment market size reached US$ 10.8 billion in 2023. The market to reach US$ 20.5 billion in 2032, exhibiting a growth rate (CAGR) of 7.4% during 2024-2032.

What are Psoriatic Arthritis (PsA) Treatment Market?

Treatment for Psoriatic Arthritis (PsA) involves addressing both joint inflammation and the skin symptoms of psoriasis, as the condition affects both aspects. Typically, a combination of medications like nonsteroidal anti-inflammatory drugs (NSAIDs), disease-modifying antirheumatic drugs (DMARDs), biologics, and corticosteroids is used to reduce inflammation, pain, and swelling in the joints. Additionally, topical treatments, phototherapy, and lifestyle changes such as exercise and weight management are often recommended to manage skin symptoms and enhance the overall quality of life for individuals with PsA.

Request for a sample copy with detail analysis: 

What are the growth prospects and trends in the Psoriatic Arthritis (PsA) Treatment Market industry?

The psoriatic arthritis (PsA) treatment market growth is driven by various factors. The market for treating Psoriatic Arthritis (PsA) is growing significantly due to the increasing global prevalence of the condition. This market offers a variety of treatment choices, such as nonsteroidal anti-inflammatory drugs (NSAIDs), disease-modifying antirheumatic drugs (DMARDs), biologics, and corticosteroids, all aimed at managing joint inflammation and skin symptoms. Furthermore, new therapies and biologics are emerging, expanding the range of treatments available to PsA patients. Increased awareness of PsA and its treatment options, along with rising healthcare spending in developing regions, are also contributing to the market's growth. Hence, all these factors contribute to psoriatic arthritis (PsA) treatment market growth.

What is included in market segmentation?

The report has segmented the market into the following categories:

1. By Treatment Type

Medications
NSAIDs (Nonsteroidal Anti-Inflammatory Drugs)
DMARDs (Disease-Modifying Antirheumatic Drugs)
Biologics
Physical Therapy
Lifestyle Modifications

2. By Mode of Administration

Oral
Injectable
Topical

3. By Patient Type

Newly Diagnosed
Moderate to Severe Psoriatic Arthritis
Refractory or Resistant Cases

4. By End User

Hospitals
Specialty Clinics
Ambulatory Surgical Centers
Homecare Settings

5. North America

United States
Canada

6. Europe

Germany
United Kingdom
France
Italy
Spain
Russia
Poland
Benelux
Nordic
Rest of Europe

7. Asia Pacific

China
Japan
India
South Korea
ASEAN
Australia & New Zealand
Rest of Asia Pacific

8. Latin America

Brazil
Mexico
Argentina

9. Middle East & Africa

Saudi Arabia
South Africa
United Arab Emirates
Israel
Rest of MEA

Who are the key players operating in the industry?

The report covers the major market players including:

1. AbbVie Inc.
2. Amgen Inc.
3. Johnson & Johnson
4. Pfizer Inc.
5. Eli Lilly and Company
6. Novartis International AG
7. Bristol Myers Squibb Company
8. UCB S.A.
9. Celgene Corporation (acquired by Bristol Myers Squibb)
10. AstraZeneca PLC

Discover more:

If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

About Us:

Reports and Insights consistently mееt international benchmarks in the market research industry and maintain a kееn focus on providing only the highest quality of reports and analysis outlooks across markets, industries, domains, sectors, and verticals. We have bееn catering to varying market nееds and do not compromise on quality and research efforts in our objective to deliver only the very best to our clients globally.

Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.

MENAFN22052024004629010566ID1108244961